Shares of Candel Therapeutics, Inc. (CADL) have gained 3.2% over the past four weeks to close the last trading session at $5.45, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $21 indicates a potential upside of 285.3%.The average comprises four short-term price targets ranging from a low of $15 to a high of $25, with a standard deviation of $4.90. While the lowest estimate ind ...

Mind Medicine (MindMed) Inc. (MNMD) closed the last trading session at $7.26, gaining 4.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $24.50 indicates a 237.5% upside potential.The mean estimate comprises 10 short-term price targets with a standard deviation of $12.13. While the lowest estimate of $16 indicates a 120.4% increase from the current price level, the most optimisti ...

Core Viewpoint - Ooma (OOMA) has shown an 8.8% increase in stock price over the past four weeks, with a mean price target of $18.30 indicating a potential upside of 34.1% from the current price of $13.65 [1] Price Targets and Analyst Estimates - The mean estimate consists of five short-term price targets with a standard deviation of $1.10, where the lowest estimate is $17 (24.5% increase) and the highest is $20 (46.5% increase) [2] - A low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about Ooma's earnings prospects, with a positive trend in earnings estimate revisions correlating with potential stock price increases [4][11] - The Zacks Consensus Estimate for the current year has risen by 6.2% over the past month, with three estimates increasing and no negative revisions [12] Zacks Rank and Investment Potential - Ooma holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting exact gains, they can indicate the direction of price movement [13]

Group 1 - Broadwind Energy, Inc. (BWEN) shares have declined by 11.7% over the past two weeks, but a hammer chart pattern formed in the last trading session suggests potential support and a possible trend reversal [1] - The hammer pattern indicates a technical signal of nearing a bottom, with reduced selling pressure, and is supported by a strong consensus among Wall Street analysts raising earnings estimates for BWEN [2][7] - The consensus EPS estimate for BWEN has increased by 23.1% over the last 30 days, indicating analysts' agreement on the company's potential for better earnings [8] Group 2 - The Zacks Rank for BWEN is currently 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which typically outperform the market [9] - A Zacks Rank of 2 serves as a strong indicator of a potential trend reversal, as it helps identify when a company's prospects are improving [9]

Pagaya Technologies Ltd. (PGY) closed the last trading session at $17.13, gaining 50.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $22.03 indicates a 28.6% upside potential.The mean estimate comprises nine short-term price targets with a standard deviation of $6.97. While the lowest estimate of $13.75 indicates a 19.7% decline from the current price level, the most optimistic ...

Core Viewpoint - Nexxen International Ltd. (NEXN) has seen a 16.4% increase in share price over the past four weeks, closing at $11.72, with a potential upside of 25.2% based on Wall Street analysts' mean price target of $14.67 [1][11]. Price Targets and Analyst Estimates - The mean estimate consists of nine short-term price targets with a standard deviation of $2.55, indicating variability among analysts; the lowest estimate is $9 (23.2% decline), while the highest is $18 (53.6% increase) [2][9]. - A low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement direction, which can serve as a starting point for further research [9]. Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about NEXN's earnings prospects, as evidenced by a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11][12]. - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 10.8%, with one estimate moving higher and no negative revisions [12]. Zacks Rank and Investment Potential - NEXN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating a strong potential for upside in the near term [13].

Shares of Janus International Group, Inc. (JBI) have gained 18.5% over the past four weeks to close the last trading session at $8.25, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $10.90 indicates a potential upside of 32.1%.The mean estimate comprises five short-term price targets with a standard deviation of $2.97. While the lowest estimate of $7.50 indicates a 9.1% decline ...

Evolv Technologies Holdings, Inc. (EVLV) closed the last trading session at $5.46, gaining 30% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $7.06 indicates a 29.3% upside potential.The mean estimate comprises four short-term price targets with a standard deviation of $1.16. While the lowest estimate of $5.50 indicates a 0.7% increase from the current price level, the most optimi ...

Crexendo (CXDO) closed the last trading session at $5.35, gaining 5.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $8.30 indicates a 55.1% upside potential.The mean estimate comprises five short-term price targets with a standard deviation of $0.97. While the lowest estimate of $7.50 indicates a 40.2% increase from the current price level, the most optimistic analyst expects th ...

Core Viewpoint - Arvinas, Inc. (ARVN) shows significant upside potential with a mean price target of $14.62, indicating a 94.9% increase from the current price of $7.50 [1] Price Targets and Estimates - The mean estimate consists of 17 short-term price targets with a standard deviation of $5.19, suggesting variability in analyst predictions [2] - The lowest estimate of $8 indicates a 6.7% increase, while the highest estimate suggests a 233.3% surge to $25 [2] - A low standard deviation indicates strong agreement among analysts regarding the stock's price movement [9] Analyst Sentiment and Earnings Estimates - Analysts have shown increasing optimism about ARVN's earnings prospects, as evidenced by a positive trend in earnings estimate revisions [11] - The Zacks Consensus Estimate for the current year has risen by 56.9% over the past month, with 11 estimates increasing and one decreasing [12] - ARVN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]